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ABBREVIATIONS 
 
A: Asthma 
(n)Act c 10: (natural) LTP1 from  Actinidia chinensis  
(n)Act d 10: (natural) LTP1 from Actinidia deliciosa 
(n)Act d 5: (natural) kiwellin from Actinidia deliciosa 
ANG: angioedema 
(n)Api g 2: (natural) LTP1 from Apium graveolens 
(r)Ara h 9: (recombinant) LTP from Arachis hypogaea 
ARG-C: proteinase that preferentially cleaves the C-terminal 
side of arginine residues 
(n)Art v 3: (natural) LTP1 from Artemisia vulgaris 
ASP-N: proteinase that preferentially cleaves the N-terminal 
side of  aspartic acid or glutammic acid 
BCIP: 5-bromo-4-chloro-3-indolyl-phosphate 
BSA: bovin serum albumin  
CD: Circular Dichroism 
(n)Cit s 3: (natural) LTP1 from Citrus sinensis 
COX-2: cyclooxygenase-2 
(r)Cor a 8: (recombinant) LTP1 from Corylus avellana 
CrD: Crohn’s Deasese 
CRD: component resolved diagnosis 
CW: cell wall 
D: Diarrhea 
DBPCFC: Double-Blind  Placebo Controlled Food Challenge 
test 
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DMSO: Dimethyl Sulfoxide 
2D-NMR: Bidimensional Nuclear Magnetic Resonance 
E: Edema 
EC-LPS: Escherichia Coli Lipopolysaccharide 
ELISA: Enzyme-Linked ImmunoSorbent Assay 
EST: expressed sequence tag 
FPLC: Fast Protein Liquid Chromatography 
(n)Fra a 3: (natural) LTP1 from Fragaria ananassa 
GI: gastrointestinal symptoms 
HFIP: hexafluoroisopropanol 
(n)Horvu: (natural) LTP2 from Hordeum vulgare 
ICAM-1: Inter-Cellular Adhesion Molecule 1 
ISAC: Immuno Solid-phase Allergen Chip 
ISAC79: ISAC with 79 spotted allergens 
ISAC103: ISAC with 103 immobilized allergens  
ISAC-Exp96: experimental ISAC with 96 immobilized 
allergens 
(n)Lac s 1: (natural) LTP1 from Lactuca sativa 
(n)Len c 3: (natural) LTP1 from Lens culinaris 
 (n)Lyc e 3: (natural) LTP1 from Solanum lycopersycum 
(n)Lyc 7 kDa: (natural) LTP2 from Solanum Lycopersycum  
LTP: Lipid Transfer Protein 
(n)MAIZE: (natural)  LTP2 from Zea mais 
(n)Mal d 3: (natural) LTP1 from Malus domestica 
MALDI -TOF: Matrix Assisted Laser Desorption Ionization 
Time Of Flight 
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(n)Mor n 3: (natural) LTP1 from Morus nigra 
NCBI: National Center for Biotechnology Information 
NBT: Nitro Blue Tetrazolium 
NR: No Result 
O: Oral symptoms 
OAS: Oral Allergy Syndrome 
(n)Ory s 14: (natural) LTP1 from Oryza sativa 
(n)ORYSJ: (natural) LTP2 from Oryza sativa 
P: skin itching 
(r)Par j 2: recombinant LTP1 from Parietaria judaica 
PBS: phosphate buffer saline 
(n)Pla or 3: (natural) LTP1 from Platanus orientalis 
(n)Pru ar  3: (natural) LTP1 from Prunus armeniaca 
(n)Pru av 3: (natural) LTP1 from Prunus avium 
(n)Pru d 3: (natural) LTP1 from Prunus domestica 
(n)Pru p 3: (natural) LTP1 from Prunus persica 
(n)Pru du 3: (natural) LTP1 from Prunus dulcis 
(n)Pyr c 3: (natural) LTP1 form Pyrus communis 
PVDF: polyvinylidene fluoride 
RP-HPLC: Reversed-Phase High-performance liquid 
chromatography 
(n)Rub i 3: (natural) LTP1 from Rubus idaeus 
SDS-PAGE: polyacrylamide gel electrophoresis in sodium 
dodecyl sulfate 
SGF: Simulated Gastric Fluid 
SF:  soluble fraction 
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SIF: Simulated Intestinal Fluid 
(n)Sin a 3: (natural) LTP1 from Brassica alba 
(n)SOLTU: (natural) LTP2 from Solanum tuberosum 
(n)SOYBN: (natural) LTP2 from Glicine max 
SPHIAa: Single Point Highest Inhibition Achievable assay 
SPT: Skin Prick Test 
TBS-T: tris buffer saline tween 
TFA: trifluoro acetic acid 
TFE: 2,2,2- trifluoroethanol 
TNF-alfa: Tumor Necrosis Factor-alpha 
(n)Tri a 14: (natural) LTP from Triticum aestivum 
U: Urticaria 
 URT: urticaria 
V: Vomiting 
(n)Vit v 1: (natural) LTP1 from Vitis vinifera 
(n)WHEAT: (natural) LTP2 from Triticum aestivum 
(n)Zea m 14: (natural) LTP1 from Zea mays 
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ABSTRACT 
 
Foods can affect human health beyond basic nutritional 
effects. In fact, foods are a source of different molecules, 
including nutraceuticals, i.e. health-promoting molecules, 
and proteins that can cause allergic reactions. The objectives 
of this thesis are in the framework of a research program 
focused on the study of allergens and nutraceuticals from 
plant foods and their possible effects on human health. 
Kiwifruit has been chosen as a model of food endowed with 
beneficial effects on human health and also an important 
source of food allergy, although for comparative purposes 
other foods have sometimes been included in the study.  
 Four new allergens have been identified in plant food, 
namely green and gold kiwifruit, black mulberry and tomato. 
They belong to the family of Lipid Transfer Proteins (LTP) 
and three of them have already been  included in the official 
list of allergens of the World Health 
Organization/International Union of Immunological 
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Societies (WHO/IUIS) with the allergen  names Act d 10, Act 
c 10 and Mor n 3. The structural properties of these allergens 
have been characterized using classical biochemical 
methodologies. The immunological and clinical features have 
been investigated using both classical methodologies, such as 
skin prick test, prick by prick test and DBPCFC, and 
emerging methodologies, such as the high throughput ISAC 
system allowing analysis by multiplex biochip-based 
immunoassay. The results obtained by comparative analysis 
show a heterogeneous behavior of different LTPs indicating 
that the biochemical grouping of allergens can be misleading 
in the allergy diagnosis and that an improved allergy 
diagnosis can be obtained by testing every single patient with 
the most comprehensive panel of available LTPs/allergens .  
The influence of different experimental conditions on the 
structural properties and IgE reactivity of the kiwifruit 
allergen kiwellin (Act d 5) was investigated by circular 
dichroism, skin testing, immunoblotting and ISAC 
microarray system. Results obtained demonstrated that the 
physico-chemical features of the environment can affect the 
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conformation and the IgE reactivity of Act d 5. This behavior 
suggests that the environmental conditions may affect the 
response of allergy diagnostic systems by modulating the 
pattern of exposed antigenic epitopes. 
The functional characterization of kissper, a naturally 
occurring kiwifruit peptide, performed by 
immunohystochemical and ELISA experiments on human 
colonic mucosa deriving from biopsy carried out on subjects 
suffering from Crohn’s desease, clearly indicated an 
antinflammatory effect of this molecule. This result suggests 
a possible use of kissper as a nutraceutical molecule in the 
treatment of inflammation. 
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INTRODUCTION 
 
Health and disease rely on different factors. In this context, 
environment and food quality play an important role, being 
sometimes causes of positive or negative effects on human 
health. For instance, some foods are a source of 
nutraceuticals, i.e. molecules providing health benefits, 
beyond the nutritional aspects. Nevertheless, some subjects 
have to avoid some foods because they are also sources of 
allergic reactions.  
 
1. Allergic deasese 
Allergies are undesiderable reactions produced by the 
normal  immune system. Allergic reactions occur when the 
immune system reacts against normally harmless substances 
present in the environment. The name “allergen” is given to a 
molecule that can cause an allergic reaction. 
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When subjects with allergic deaseses are exposed to common 
environmental substances, such as house dust mite or grass 
pollen or foods, a type of white blood cells (B lymphocytes) 
produce specific antibodies known as Immunoglobuline E 
(IgE) against protein molecules contained in that substance 
(sensitization). This IgE then attaches itself to another type of 
white blood cell (mast cells), and when the mast cells come 
into the contact with that substance again, they initiate a 
complex immune response that leads to the allergy (Figure1). 
 
Figure 1. Release of inflammatory mediators, like histamine, from a mast cell 
after interaction of allergens with specific IgE present on the cell surface.  
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It was estimated that more than 80 million people in Europe 
have an allergic disease, with a dramatically increasing 
prevalence over the last 20-30 years. Literature data report 
that allergic deaseses are on the rise and are no longer 
confined to specific seasons, or to people living in specific 
areas (1). The recent escalation of allergic deasese may be at 
least partially attributable to environmental factors: people 
are now exposed to several different substances, both natural 
and man-made. Psychological stress is also thought to be 
linked to allergic disorders as modern living and hectic 
lifestyles have an increasingly negative impact (2). 
The effect of allergy on sensitive individuals can be 
substantial, and the common symptoms include breathing 
difficulty, coughing, repeated sneezing, itchy, swollen and 
rose nose and eyes, eczema and dermatitis. In very serious 
cases, an anaphylactic reaction can be fatal. The list of the 
substances to which people are commonly allergic include 
house dust mite, pollens from grasses and trees, animal 
dander (including cat, dog and horse) moulds, foods 
(including tree nuts, peanuts, shellfish, fish, milk, eggs, 
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wheat, fruits) and latex. Different allergic subjects can show 
different symptoms when they are exposed to the substances 
they are allergic to. 
A phenomenon called cross-reactivity may occur when an 
antibody reacts not only with the allergen that caused the 
sensitization, but also with homologous proteins. In food 
allergy cross-reactivity occurs when a food allergen shares 
structural similarities with a different food allergen or 
aeroallergen. 
 
1.1. Food allergy 
 
Food allergy is an abnormal response to specific protein 
components of food, triggered by the immune system. The 
reactions can range from  mild symptoms, such as dermatitis, 
vomiting and diarrhea, to severe ones, such as the 
anaphylactic reaction. 
Some allergens, most often from fruits and vegetables, cause 
allergic reactions especially if eaten when raw. However, 
most food allergens can still cause reactions after they have 
been cooked or have undergone digestion, because some of 
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them are resistant to high temperature and to gastric and 
intestinal digestion. 
 
1.1.1. Lipid Transfer Proteins (LTP) 
Plant Lipid transfer proteins (LTP) are small proteins that are 
divided in two sub-families according to their molecular 
masses, namely LTP1 those having a molecular mass of 9 kDa 
and LTP2 those with a molecular mass of 7 kDa. Although 
LTP1 and LTP2 share a common compact fold consisting of 
four -helices stabilized by four disulfide bridges, the pairing 
partners of cysteines are not completely conserved between 
the two subfamilies, that also display a low overall sequence 
similarity (about 30% identity) (3). LTPs are reported to be 
involved in defence mechanisms (4), pollination and 
germination (5, 6). However, the in vivo biological function 
remains elusive. LTPs are thermostable and resistant to the 
proteolytic digestion. Probably due to the extreme resistance 
to the gastrointestinal digestion, LTP is a severe food allergen 
that can cause anaphylaxis (7). 
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Up to now 63 LTPS have been reported as allergens, 46 of 
them expressed in edible parts of plants and all of them 
belonging to the LTP1 protein subfamily. Among allergenic 
LTPs, the best characterized at the structural, immunological 
and clinical level is the peach LTP1, Pru p 3 (Figure 2). It is an 
allergen that can cause severe symtoms and one of the most 
important allergic sensitizers in the Mediterranean area. 
Several reviews on the topic of LTP as allergens reported 
preliminary evidence of a heterogeneous behavior of this 
group of molecules (8, 9). 
 
 
 
 
 
 
 
Figure 2. Molecular structure of the allergenic peach LTP1, Pru p 3. 
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1.2. Diagnosis of allergic deasese 
To date the best treatment of allergic subjects is based on the 
avoidance of the allergen source. The implication is that a 
proper management of allergic subjects requires a highly 
reliable diagnosis in order to identify the  molecules that each 
patient has to avoid. However, the allergenic molecules 
identified so far are much less than those actually contained 
in the allergenic sources. In addition, sometimes diagnostic 
systems produce wrong results showing false positive or 
negative responses.  
Several in vitro and in vivo test systems are available and 
currently used to investigate the causes of individual allergic 
reactions. Usually, data from more than one test system are 
comparatively evaluated in the attempt to reach a reliable 
diagnosis. In vivo  Skin Prick Testing (SPT) and in vitro blood 
tests are usually used for this purpose. Sometimes it is 
necessary to perform a provocation or “challenge test” with 
the suspected food, that involves the introduction of a 
specific food to the patient in gradually and increasing 
amounts and in very controlled conditions. The challenge test 
18 
 
must be performed in a hospital where any serious reaction 
can be safely managed. 
The traditional test systems are based on the use of 
commercially available protein extracts derived from the 
allergy sources. However, they frequently fail to detect 
specific IgE because their composition can be very variable. 
Ripening stage, post-harvest treatments, proteolytic 
degradation and protocols used for the extraction 
significantly affect the relative amounts of many proteins and 
the profile of allergenic components (10)(11)(12). 
Since it seems impossible to obtain standardized extracts 
with a costant allergenic composition and containing all the 
allergenic proteins present in the natural source, component 
resolved diagnosis (CRD) has gained more attention in the 
recent past. In fact, the research and the commercial 
companies are  evolving through the development of new 
tecnologies useful for the detection of specific IgE against 
purified recombinant or natural allergens. Among the novel 
metodologies we find the increasing use of diagnostic 
systems allowing the simultaneous measurement of IgE 
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antibodies specific for different individual allergens (i.e. 
multiplex analysis) with the same serum sample (13).  
 
1.2.1. ISAC microarray system 
ISAC (Immuno Solid-phase Allergen Chip) is an in vitro 
diagnostic system useful for semiquantitative analysis of 
immunoglobulin E (IgE) in the serum samples (14)(15). In 
contrast with the traditional systems, the ISAC system do not 
use any protein extract. It uses only purified allergens 
(component resolved diagnosis, CRD) allowing a better 
standardization of the tests. It is a chip containing four 
identical reaction chambers (Figure 3A) and each chamber is 
a microarray where purified natural and recombinant 
allergens are immobilized separately (Figure 3B). The IgE 
contained in the serum of an allergic subject recognize one or 
more immobilized allergens on the microarray (Figure 4A) 
and the interaction is revealed using an antibody, conjugated 
with a fluorescent probe, specific for human IgE (Figure 4B). 
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Figure 3. ISAC system. Chip with 4 reaction chambers (A) and purified 
allergens spotted on the microarray (B).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. IgE-allergen interaction is revealed by a fluorescent dye 
conjugated with an anti-IgE antibody. (A) The allergenic proteins 
immobilized on the chip are in blue, the human IgE are in red and the 
anti-IgE are in yellow. (B) The fluorescence intensity is mesured with a 
“microarray scanner”  
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In some allergological centers, this system is routinely used 
for allergy diagnosis providing information on the subjects’  
sensitivity to all the allergens available on the microarray 
with a single test (16, 17).  
Few years ago the first version of the ISAC microarray 
become commercially available. It had 79 different  allergenic 
proteins spotted on the microarray (ISAC79). The number of 
allergens immobilized on this microarray is growing and at 
present a microarray with 103 allergens (ISAC103) is 
available.   
 
2. Nutraceuticals in plant food  
Regular consumption of fruit and vegetables is generally 
associated with a reduction of the risk of several human 
pathologies, such as cardiovascular diseases, heart failure, 
microbial infections, cancer, Alzheimer’s disease and other 
age-related functional degenerations (18)(19). These 
advantages are usually ascribed to rich vitamin and 
antioxidants, although other kind of still unknown molecules 
could have beneficial effects on human health. (20). 
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Kiwifruit is one of the foods at which different types of 
health-promoting effects have been ascribed and reported in 
the literature. 
 
2.1. Kiwifruit 
Kiwifruit is indigenous to southern Asia. The vines can be 
found growing wild on the edges of forests near the Yangtze 
River Valley. The kiwifruit plant belongs to the family 
Actinidia. Although there are around 400 varieties, the ones 
most widely grown for commercial fruiting purposes are 
Actinidia deliciosa, which has a green flesh, and more recently 
Actinidia chinensis, also known as the gold kiwifruit or 
“Chinabelle”, which has a yellow flesh and is sweeter and 
less acidic than the green variety (Figure 5). 
Kiwifruit is reported as a food with significant effects on 
human health. For instance, this fruit was used by traditional 
Chinese medicine for the prevention and therapy of many 
different kinds of cancers (21). More recently, a number of 
experimental data suggested the presence of several 
23 
 
biological activities associated to kiwifruit, beyond basic 
nutrition. 
 
 
 
 
 
 
Figure 5. Green (Actinidia deliciosa) and gold (Actinidia chinensis) 
kiwifruit. 
 
 
For instance, in vitro cytotoxicity towards tumor cell lines and 
antimicrobial activity (21), protection against oxidative DNA 
damage, (22) and cardiovascular protective properties (23) 
were reported. Data from human trials indicated that daily 
consumption of kiwifruit promoted laxation in ederly people 
(24). In vitro experiments showed that the protein thaumatin, 
isolated from kiwifruit, displays antifungal and antiviral 
(anti-HIV) activities against human pathogens (25). 
Unfortunately, some subjects have to avoid the consumption 
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of kiwifruit because it is also an important source of food 
allergens. Actinidin, kiwellin and thaumatin are the three 
most abundant proteins found in green kiwifruit (12). In the 
gold species, kiwellin is the major protein component. 
Literature reports show that all these three kiwifruit proteins 
have allergenic properties (25)(26)(27).  
 
2.1.1. Kissper, a kiwifruit peptide with channel-like activity 
It has been demonstrated that kiwellin may undergo in vivo 
and in vitro proteolytic processing by the protease actinidin 
originating KiTH and kissper (28). KiTH is a 16-kDa 
polipeptide corresponding to the C-terminal region of 
kiwellin. Kissper is a 4-kDa peptide corresponding to the N-
terminal region of kiwellin. Kissper can be isolated in 
significant amounts from the edible part of ripe green 
kiwifruit. The elucidation of the primary structure of kissper 
revealed that it is a cysteine-rich peptide of 39 residues.  
2D NMR experiments indicated that kissper has a compact 
structure, stalilized by three disulfide bridges and only short 
25 
 
regions of regular secondary structure, without any evident 
similarity with other bioactive peptides (Figure 6). 
 
 
Figure 6. Ribbon representation of kissper solution structure. The three 
disulfide bridges are shown in yellow 
 
 
Functional characterization has shown that kissper is able to 
form voltage-gated ion channels preferentially transporting 
anions, such as Cl-, through model plasmatic membranes (29). 
This property suggests a possible positive effect of this 
molecule in the treatment of pahtologies characterized by 
insufficient anion transport. 
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OBJECTIVES 
 
Several factors may affect human health. In this context, food 
quality plays an important role, being sometimes a cause of 
positive or negative effects on human health and desease. For 
instance, some foods are a source of nutraceuticals, i.e. 
molecules providing health benefits, beyond the basic 
nutritional aspects. Nevertheless, some subjects cannot eat 
some foods because they are also sources of allergenic 
components. 
The objectives of this thesis are in the framework of a 
research program focused on the study of allergens and 
nutraceuticals from plant foods and their possible effects on 
human health. Kiwifruit has been chosen as a food model, 
although for comparative purposes other foods are 
sometimes included in the study.  
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Identification, purification and characterization of 
allergenic proteins from plant food. 
At present, the recommended treatment of allergic subjects is 
based on the avoidance of the allergen source. The 
implication is that an adeguate management of allergic 
subjects requires a highly reliable diagnosis in order to 
identify the molecules that each allergic subject has to avoid. 
However, the allergenic molecules identified so far are much 
less than those actually contained in the allergenic sources. In 
addition, the available test systems sometimes produce false 
results that can be due to several factors.  
  
1. With the aim of contributing to the elucidation of 
allergomes of different allergenic foods, the identification and 
biochemical and immunological characterization of new 
allergens from different plant sources have been planned. In 
particular, we sought to identify and characterize the allergen 
Lipid Transfer Protein (LTP) from different allergenic 
sources, such as green and gold kiwifruit, black mulberry 
and tomato.  
28 
 
 
2. Allergenic LTPs have also been chosen as a model to 
investigate how heterogeneous is the immunological 
behavior of homologous allergenic proteins. At present, the 
concept “one allergenic molecule fits all the homologs” is 
widely applied in allergy diagnosis. To investigate the 
validity of this concept, a comparative analysis of the 
immunological properties of homologous LTPs from 
different sources was included in the aims of this study.  
 
3. The protein nature of allergens makes these molecules 
sensitive to the physico-chemical features of the environment 
that can affect their structural properties. In this context, a 
further aim of this thesis was the study of the influence of 
different experimental conditions on the structural and 
immunological properties of the allergen kiwellin (Act d 5). 
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Characterization of the bioactive peptide kissper, isolated 
from kiwifruit. 
A peptide, named kissper, able to form voltage-gated ion 
channels, preferentially transporting anions, such as Cl- ions, 
through model plasmatic membranes was identified in 
kiwifruit. The funtional properties of this food molecule 
prompted the investigation of the effect of kissper on human 
intestinal tissues following appropriate markers of 
inflammation. 
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MATERIALS AND METHODS 
 
MATERIALS 
 
Black mulberry (Morus nigra), gold kiwifruit (Actinidia 
chinensis), green kiwifruit (Actinidia deliciosa), tomato 
(Solanum lycopersicum) used for the purification of the 
allergenic LTPs, Mor n 3, Act c 10, Act d 10 and Lyc e 7kDa, 
respectively, were purchased in local markets. Peach fruit 
(Prunus persica cv Stark Saturn) used for the purification of 
Pru p 3 was kindly provided by the CRA-FRC Fruit farming 
Research Unit, Caserta, Italy. 
 
METHODS 
1. Protein extracts  
1.1.Preparation of the protein extracts from whole kiwifruit 
Gold kiwifruit (Actinidia chinensis) and green kiwifruit 
(Actinidia deliciosa), were peeled, homogenized in a 
household blender after addition of 1M NaCl (1:1, w/v) and 
stirred a 4°C for 2 h. After centrifugation at 12500  g for 60 
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min, the supernatant representing the total protein extract, 
was collected, dialyzed against water, aliquoted and stored at 
-20°C until used.  
 
1.2. Preparation of the protein extracts from pulp and seeds of 
kiwifruit 
Seeds of gold and green kiwifruits were manually separated 
from the pulp. Pulp samples were homogenized in a blender 
after addition of 1M NaCl (1:1, w/v) and stirred at 4 °C for 2 
h. Seeds were crushed by pestle in a mortar until a smooth 
powder was obtained. Seed proteins were extracted in 0.5 M 
NaCl at 4 °C for 2 h. After protein extraction, pulp and seed 
samples were centrifugated at 12500  g for 60 min and the 
supernatants were collected. 
 
1.3. Estimation of the protein concentration 
The protein concentration in the extracts and in the purified 
protein preparations was estimated by the BIO-RAD Protein 
Assay (Bio-Rad, Milan, Italy), using calibration curves made 
with bovine serum albumin. 
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1.4. Fractionation of protein extracts by RP-HPLC 
RP-HPLC of extracts was performed on a Vydac (Deerfield, 
IL, USA) C8 column (0.21  25 cm), using a Beckman Gold 
Apparatus (Fullerton, CA, USA). Elution was carried out by a 
multistep linear gradient of eluent B (0.08 % TFA in 
acetonitrile) in eluent A (0.1 % TFA in water) at a flow rate of 
1 ml/min. The eluate was monitored at 220 and 280 nm. The 
separated fractions were manually collected and analyzed. 
 
2. Proteins and peptide purification 
2.1. Purification of LTP from black mulberry. 
The black mulberry fruit was homogenized in water (1:1, 
w/v) and centrifuged at 10400 x g for 30 min. The 
supernatant was discarded and the pellet, containing the cell 
wall fraction, was collect and homogenized again after 
addition of 0.5 M NaCl. After a 60 min extraction followed by 
centrifugation, the supernatant was collected, dialyzed 
against 10 mM Tris-HCl, pH 7.2, and loaded on a DE52 
(Whatman, Brentford, UK) column, equilibrated in the same 
buffer. LTP was eluted in the column flow-through. The 
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sample was then adjusted to pH 5.0 and loaded on a SP-
Sepharose (Amersham Biosciences, Uppsala, Sweden)  
column, equilibrated in 10 mM sodium acetate, pH 5.0 (buffer 
A). Elution was carried out by increasing the concentration of 
buffer B (50 mM sodium acetate, pH 5.0, containing 0.5 M 
NaCl). The fractions containing LTP were identified 
following the analysis by RP-HPLC using a Vydac (Deerfield, 
IL, USA) C8 column and a Beckman System Gold apparatus 
(Fullerton, CA, USA). LTP was further purified by RP-HPLC. 
Elution was obtained by a linear gradient of eluent B (0.08% 
TFA in acetonitrile) in eluent A (0.1% TFA). The LTP eluted 
by RP-HPLC was manually collected and dried in a rotary 
vacuum centrifuge. 
After several washing with water,  the protein samples were 
dried and stored at -20 °C until required. Protein 
concentration was estimated on the basis of the molar 
extinction coefficient at 280 nm of 3480 M-1 cm-1. Purity of the 
protein preparation was checked by SDS-PAGE, RP-HLPC 
and N-terminal amino acid sequencing. 
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2.2. Purification of LTP from green and gold kiwifruit and from 
tomato 
LTPs from kiwifruit seeds, peach peel and tomato seeds were 
purified using the procedure described above for black 
mulberry LTP. Purity of the protein preparations were 
checked by SDS-PAGE, RP-HLPC and N-terminal amino acid 
sequencing. 
 
2.3. Purification of kiwellin (Act d 5) from green kiwifruit 
Kiwi fruit were homogenized in water. After centrifugation, 
the supernatant, representing the soluble fraction (SF), was 
discarded. The pellet, containing the cell wall fraction, was 
resuspended in 0.5 M NaCl, adjusted to pH 8.3 by addition of 
NaOH, and homogenized again. After centrifugation, the 
supernatant (cell wall salt extract, CW) was collected. A total 
protein extract was obtained homogenizing kiwi fruit in 0.5 
M NaCl, and collecting the supernatant obtained after 
centrifugation. The CW fraction, dialyzed against 10 mM 
Tris-HCl, pH 7.5, was loaded on a DE52 column equilibrated 
in the same buffer. The protein was eluted in the column 
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flow-through, which was adjusted to pH 5.0 and loaded on a 
SP-Sepharose column, equilibrated in 10 mM sodium acetate, 
pH 5.0 (buffer A). Elution was carried out by increasing the 
concentration of buffer B (50 mM sodium acetate, pH 5.0, 
containing 0.5 M NaCl). The fractions containing the 28 kDa 
band (kiwellin) upon SDS-PAGE were pooled, dialyzed 
against 10 mM sodium acetate, pH 5.0, and purified by FPLC 
ion-exchange chromatography carried out on a Mono-S HR 
10/10 column (Amersham-Pharmacia), equilibrated in the 
same buffer (buffer A). Flow-rate was 3 ml/min. Elution was 
carried out increasing the concentration of buffer B, as above. 
The absorbance was recorded at 280 nm. 
 
2.4. Purification of the peptide kissper 
Kissper was purified following the already described 
procedure (29) with few modifications. Briefly, ripe kiwifruits 
(Actinidia deliciosa) were homogenized in water (1:1, w/v) by 
a household blender. After centrifugation, the supernatant 
was dialyzed against 10 mM Tris-HCl, pH 8.0, and loaded on 
a DE52 (Whatman, Brentford, UK)  column equilibrated in 
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the same buffer. The column was eluted with 0.5 M NaCl in 
the equilibrating buffer, and aliquots of the collected fractions 
were analyzed by RP-HPLC. The fractions containing kissper 
were dialyzed against 10 mM Tris-HCl, pH 8.0, and then 
loaded on a Mono-Q HR 10/10 column, equilibrated in the 
same buffer. The column was eluted by a linear gradient 
from zero to 0.3 M NaCl. The fractions from Mono-Q were 
analyzed by RP-HPLC, and those containing kissper were 
concentrated by ultrafiltration.  
 
3. Structural characterization of purified proteins 
3.1. N-terminal amino acid sequencing 
Amino acid sequencing of the N-terminal region of intact 
proteins under investigation or of peptides obtained by 
proteolytic digestion was performed with an Applied 
Biosystems Procise 492 automatic sequencer (Applied 
Biosystem Foster City, CA), equipped with on-line detection 
of phenylthiohydantoin amino acids.  
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3.2. Mor n 3 primary structure dermination and analysis 
Denaturation and alkylation of the LTP sulfhydryl groups 
with 4-vynilpyridine was carried out as already described 
(30). Denatured LTP was divided into three aliquots and 
subjected to the proteolytic cleavage by either trypsin, Asp-N 
and Arg-C, following manufacturer’s instructions (Roche 
Diagnostics GmbH, Mannheim, Germany). Separation of 
peptides obtained by proteolytic cleavages was performed by 
RP-HPLC on a Vydac C8 column. Elution was carried out by 
a linear gradient of eluent B (0.08% trifluoracetic acid in 
acetonitrile) in eluent A (0.1% trifluoracetic acid) at a flow 
rate of 1 ml/min. The eluate was monitored at 220 and 280 
nm. The separated fractions were manually collected and 
subjected to automated amino acid sequencing as described 
at the paragraph 3.1.  
 
3.3. Act d 10 primary structure determination and analysis 
Denaturation and alkylation of the LTP sulfhydryl groups 
with 4-vynilpyridine was carried out as already described 
(30). Denaturated Act d 10 was divided in two aliquots and 
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subjected to proteolytic cleavage to either trypsin and Asp-N, 
following manufacturer’s instructions (Roche Diagnostics 
GmbH). Due to the large size, a peptide deriving from 
digestion with Asp-N was sub-digested with chymotrypsin 
(Roche Diagnostics GmbH). Separation of peptides obtained 
by proteolytic cleavages and amino acid sequencing were 
performed as described above (paragraph 3.2).  
 
3.4. Bioinformatic analysis 
Homology search and protein sequence analysis were 
performed using softwares available on the ExPASy 
Proteomics Server (www.expasy.org). 
 
3.5. Molecular mass determination by mass spectrometry of 
purified LTPs 
The molecular mass of purified proteins was estimated by 
MALDI-TOF mass spectrometry measurements carried out 
on a PerSeptive Biosystems (Framingham, MA, USA) 
Voyager-DE Biospectrometry Workstation. Analysis were 
performed on pre-mixed solutions prepared by diluting 
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samples (final concentration 5 pmol/ml) in 4 volumes of 
matrix, namely 10 mg/ml -ciano-4-hydroxycinnamic acid in 
60% acetonitrile containing 0.3 % TFA. 
 
3.6. Circular dichroism studies on kiwellin 
Circular dichroism (CD) spectra were recorded on a JASCO J-
810 spectropolarimeter using a quartz cell of 0.1 cm path 
length. Spectra were recorded, at 25 °C, over the wavelength 
range 260-190 nm with a bandwidth of 2.0 nm and a time 
constant of 8.0 s. Spectra were baseline corrected for the 
contribution of the solvent. A protein concentration of 0.15 
mg/ml was used. CD spectra were acquired in pure water 
and in mixtures containing two different fluorinated alcohols, 
hexafluoroisopropanol (HFIP) and 2,2,2-trifluoroethanol 
(TFE), corresponding to 20/80 and 80/20 (v/v) 
water/alcohol composition. To obtain the same protein 
concentration in all samples, two stock protein solutions of 
equal concentration were prepared and adjusted at either pH 
4.5 or pH 7.5 with HCl or NaOH, respectively. Identical 
aliquots of these stock solutions were diluted by addition of 
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the same volume of water or preformed mixtures of water 
with an appropriate amount of fluorinated alcohol.  
 
4. Stability to the gastric and intestinal digestion 
4.1. Treatment of purified LTPs with SGF 
In vitro simulated gastric digestion (SGF) of Actd 10 and Pru 
p 3 was performed as described by Bublin et al. (31). LTPs 
were subjected to pepsin digestion (Roche Diagnostics 
GmbH, Germany) using an enzime/substrate ratio 1:20 w/w. 
The incubation was performed in SGF conditions (0.15 M 
NaCl adjusted with 1 M HCl to pH 2.0) at 37°C. Aliquots 
were taken at 0 and 120 min and analyzed by SDS-PAGE and 
RP-HPLC. The digestion was stopped by raising the  pH to 
7.4 by addition 50 mM sodium phosphate  pH 7.4 and the 
samples were stored at -20°C. LTP samples were subjected to 
trypsin digestion (Roche Diagnostics GmbH, Germany) using 
enzime/substrate ratio of 1:20 w/w. The incubation was 
performed in 1% ammonium bicarbonate at 37°C. Aliquots 
were taken at 0 and 120 min and analyzed by SDS-PAGE and 
RP-HPLC. The digestion was stopped by boiling the samples 
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for 2 min. The samples were dried, washed three times with 
water to remove traces of ammonium bicarbonate, 
solubilized in PBS and stored at -20°C. 
 
4.2. Kissper stability in SGF and SIF  
In vitro gastric digestion of the purified peptide was 
performed as described by Moreno et al. Kissper was 
solubilized in Simulated Gastric Fluid (SGF) (0.15 M NaCl 
adjusted to pH 2 with 1 M HCl) before the addition of pepsin 
(porcine pepsin, Roche Diagnostics GmbH, Germany) at the 
enzyme/substrate ratio of 1: 20 (w/w). The digestion was 
performed at 37°C. Aliquots were taken at 0 and 120 minutes 
and analyzed by RP-HPLC. The digestion was stopped by 
raising the pH to 7.4 by addition of 50 mM Na-Phosphate 
buffer pH 7.4. 
For intestinal digestion porcine trypsin and bovine 
chymotrypsin were used. Simulated Intestinal Fluid (SIF) was 
prepared as described in the United States Pharmacopeia, and 
consists in a mixture of trypsin and chymotrypsin in 0.05 M 
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K-Phosphate buffer pH 6.8. Digestions were performed at 
37°C, at an enzyme to protein ratio of 1:50 (w/w), both for 
trypsin and chymotrypsin. Aliquots of the digest were 
withdrawn at 0 and 120 minutes and then  loaded on a Vydac 
(Deerfield , Il, USA) C8 column  for RP-HPLC analysis,  using 
a Beckman System Gold apparatus (Fullerton, CA, USA). 
 
5. Immunological characterization 
Immunological and clinical studies, including patients’ 
selection, Skin Prick Tests and tests on the ISAC microarray, 
were carried out in collaboration with Dr Adriano Mari and 
his research group at the Center for Molecular allergology, 
IDI-IRCCS, Rome. 
 
5.1. Biotinylation of kiwifruit LTPs 
Purified Act d 10 and Act c 10 preparations (1 mg/ml in 
sodium carbonate buffer pH 8.7) were incubated with 5 times 
molar excess biotin N-hydroxysuccunimmide estere (Sigma-
Aldrich, Milano, Italy) dissolved in DMSO (Sigma-Aldrich). 
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After 3.5 hours at room temperature, the excess of reagents 
were removed by gel-filtration chromatography using a PD10 
column (Amersham Biosciences, Uppsala, Sweden) 
equilibrated in PBS. The biotinylated preparations were then 
used for coupling with streptavidin-CAP. 
 
5.2. Preparation of protein solutions for SPT 
Dialyzed protein extracts and purified LTP samples were 
solubilized in deionized water and mixed with sterile 
glycerin in a 1:1 ratio. The final proteins concentration was 
0.5 mg/ml. The LTP solutions were sterilized by membrane 
filtration through a 0.22-m filter (Millex, Millipore, Bedford, 
MA, USA), in a sterile horizontal laminar a flow hood. 
 
5.3. Preparation of kiwellin (Act d 5) and kiwifruit extract 
solutions for SPT 
For SPT, (i) the extract solution was mixed with sterile 
glycerin in a ratio 1:1 and the final protein concentration was 
1 mg/ml; (ii) aliquots of lyophilized Act d 5 were solubilized 
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in water brought to pH 7.4 by the addition of NaOH, and 
then mixed with sterile glycerin in a ratio 1:1, and the final 
protein concentration was 0.5 mg/ml. Acidified solutions of 
kiwellin were obtained by solubilizing the protein in water 
brought to pH 4.5 by the addition of HCl, and the final 
protein concentration was 0.5 mg/ml. The value of pH 4.5 
was chosen in order to test conditions as much similar to 
those of kiwi fruit as possible, trying to avoid too acidic pHs 
that could discomfort patients, whereas pH 7.4 was chosen as 
a reference condition, since commercial preparations for SPT 
have neutral pH values. Solutions for SPT were sterilized by 
membrane filtration through 0.22-μm filters (Millex, 
Millipore, Bedford, MA, USA), in a sterile horizontal laminar 
flow hood. 
 
5.4. IgE immunoblotting of kiwellin (Act d 5) 
Purified Act d 5 was subjected to 15% SDS-PAGE, transferred 
onto PVDF membrane and stained with ponceau red. Serum 
samples of patients that had shown a positive SPT were 
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selected and used in immunoblotting experiments. IgE 
immunoblotting was carried out by using the blocking 
solution and goat anti-human IgE of the Enzallergy Specific E 
kit (Bio Genetix, Fiumicino, Italy). After washing with the 
blocking solution, membranes were incubated with sera 
diluted 1 : 4 for 3 h. IgE–allergen complex was detected by 
incubation with secondary antibody, i.e. a 1 : 20 dilution of 
goat anti-human IgE conjugated to alkaline phosphatase, for 
18 h, followed by incubation with BCIP/NBT solution 
prepared according to the manufacturer’s instructions. Non-
specific binding of the anti-IgE antibody conjugate was 
estimated in a similar blotting procedure omitting the 
incubation step with patient serum. 
 
5.5. Measurement of IgE-allergen interaction by ISAC microarray  
Allergen-specific IgE were detected by ISAC (Immuno Solid-
phase Allergen chip) microarray. The microarrays containing 
the immobilized allergenic proteins were activated by 
washing with TBS (10 mM NaCl, 10 mM Tris-Cl and 0.5% 
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Tween 20, pH 8.0) for 60 min, followed by washing with 
deionized water for 10 min and then dried. Microarrays were 
then positioned in a humid chamber before adding 20 μl of 
serum on the reaction site. After incubation for 120 min at 
room temperature in the humid chamber, the microarrays 
were washed for 10 min with TBS-T and for 5 min with 
deionized water and then dried in a centrifuge. The presence 
of IgE specific for the immobilized allergens was detected 
using an anti-human IgE labeled with fluorescein 
(Pharmingen, San Diego, CA), diluted 1:1000 in TBS-T 
containing 5 % milk powder. The microarrays were then 
washed in TBS-T for 10 min, in deionized water for 5 min and 
then dried and stored in the dark. The fluorescence intensity 
was measured at 543 nm by a ProScanArray HT Microarray 
scanner (PerkinElmer).  
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5.6. Inhibition Assay of IgE allergen interaction by SPHIAa 
method 
IgE inhibition experiments were performed applying the 
SPHIAa (Single Point Highest Inhibition Achievable assay) 
assay as already reported (32). Briefly, 20 μl of patients’sera 
were incubated overnight, at room temperature, with 20 μl of 
a solution containing protein extracts or purified allergen 
preparations used as inhibitors. Then, IgE binding inhibition 
was evaluated by running the ISAC microarray, as described 
in the previous paragraph. 
 
6. Treatment of intestinal tissues with the peptide kissper 
6.1. Patiens and ex-vivo organ cultures 
Biopsy specimens were taken from uninflamed mucosal areas 
immediately next to inflamed tissues of 14 patients suffering 
from Crohn’s desease (CrD) (16-41 years). The primary site of 
involvement was ileal in 4 patients, ileocolonic in 4 patients 
and colonic in 5 patients. Normal controls (18-29 years) 
included mucosal samples taken from 4 patients. Informed 
consent was obtained from all individuals, and the study was 
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performed according to the local ethical committee. One 
specimen from each patient was used for diagnosis; the other 
samples were cultured in vitro for 4 and 24 h with medium 
alone, EC-LPS (1g/ml Escherichia coli Lipopolysaccharide, 
Sigma-Aldrich, Milan, Italy) in the presence or absence of the 
peptide kissper 10g/ml. 
 
6.2. Immunolocalization in human tissue sections 
Five m thick cryostat sections were fixed in acetone for 10 
min. The sections were individually incubated for 2 h at room 
temperature with the following antibodies: COX-2 (rabbit 
polyclonal, Cell Signaling Technology, Danvers, 
Massachusetts, USA) and ICAM-1 (rabbit polyclonal, 
SantaCruz Biotechnology, Santa Cruz, CA, USA). Antigen 
expression and distribution was visualized using donkey 
anti-rabbit IgGs conjugated to Alexa Fluor 488 for 60 min at 
room temperature. Data were analyzed under fluorescence 
examination using a LSM510 Zeiss confocal laser scanning 
unit (Carl Zeiss, Germany). COX-2 and ICAM-1 positive 
mononuclear cells (MNC) were counted per mm2 of mucosa. 
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6.3. Detection of TNF-alfa by ELISA 
TNF-alfa secretion was measured using the BD OptEIATM 
ELISA kit II (BD Biosciences) in accordance with the 
manufacturer’s instructions. Protein concentrations of whole-
cell lysates were measured using the BioRad Dc protein 
Assay (BioRad). TNF-alfa levels were normalized to standard 
protein concentrations. 
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RESULTS 
 
1. Identification and biochemical and immunological 
characterization of allergenic LTPs from plant food (33, 34) 
1.1. Purification of Mor n 3 
Black mulberry LTP (Mor n 3) was purified from the fruit 
protein extract as described in the Materials and Methods 
Section.The recovery of the pure protein was 1 mg/100 gr of 
black mulberry. Protein concentration was estimated on the 
basis of the molar extinction coefficient at 280 nm (3480 M-1 
cm-1). Protein preparation resulted pure upon analysis by 
SDS-PAGE and Coomassie staining, RP-HPLC and N-
terminal amino acid sequencing. 
 
1.2. Primary Structure Elucidation of Mor n 3  
The first twenty-seven residues of Mor n 3 were elucidated 
by direct sequencing of the N-terminal region of the native 
protein. The complete primary structure was determined by 
automated sequencing of peptides deriving from enzymatic 
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digestion of denaturated and S-pyridylethilated protein. 
Most of the primary structure was elucidated by aligning the 
amino acid sequence of peptides from trypsin digestion. The 
sequence of the regions corresponding to the residues 40-44 
and 86-91 were obtained by sequencing peptides from Arg-C 
and Asp-N digestions, respectively. In Figure 7 only the 
peptides necessary to elucidate the  
 
 
Figure 7. Amino acid sequence of black mulberry LTP, Mor n 3. 
Arrows indicate fragments obtained by enzymatic digestion with 
trypsin (T), Arg-C (R) and Asp-N (D) . The amino acid sequence of the 
N-terminal region obtained by direct sequencing of the entire molecule 
is indicated by N-term. 
Peptides are numbered according to their order in the sequence. 
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complete primary structure are indicated. The sequence of 
black mulberry LTP comprises 91 amino acids producing a 
molecular mass of 9,246 Da. This value is in good agreement 
with the value obtained by MALDI-TOF mass spectrometry 
(9,235± 20 Da). 
 
1.3. Homology Search and structure analysis of Mor n 3 
Homology search in Uniprot protein database performed 
using BLAST algorithm (www.expasy.org) has shown that 
the amino acid sequence of Mor n 3 displays high sequence 
identity with several LTPs. The sequence identities observed 
for some of them, showing values ranging from 62% to 75% 
are shown in Table 1. Figure 8 shows the alignment of the 
amino acid sequence of Mor n 3 with those of some 
homologs, namely Fra a 3, Pru p 3, Vit v 1, Cor a 8, Art v 3 
and Par j 2. In order to align Par j 2, displaying significant 
sequence differences, including the presence of 11 additional 
residues, it was necessary to insert two gaps in the LTP1 
sequences. Nevertheless, 3D modelling (Figure 9) showed 
that, as for many other LTPs, the overall folding is conserved 
53 
 
 
 
Table 1. Amino acid sequence identity (%) among LTPs from different 
sources 
 
 
 
 
 
Figure 8. (A) Multlipe sequence alignment. Alignment of the amino 
acid sequences of mulberry (Mor n 3), strawberry (Fra a 3), peach (Pru p 
3), grapes (Vit v 1), hazelnut (Cor a 8), artemisia (Art V 3), and 
Parietaria judaica (Par j 2) allergens.  
Residues which have been shown to be relevant for IgE binding activity 
in Pru p 3 (green) and conserved in other sequences (pink) have been 
highlighted. 
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Figure 9. Molecular models of Mor n 3, Pru p 3 and Par j 2 allergens 
determined by using the services of the Swiss-Model Protein Modelling 
Server using the structure of a maize lipid transfer protein as a 
template. 
 
 
in Pru p 3, Mor n 3 and Par j 2. In Figure 8, three regions 
comprising the residues 11-25, 31-45 and 71-80, reported to be 
relevant for IgE binding in Pru p 3, have been highlighted 
(35). The Figure shows that the amino acid residues 
contained in these regions are only partially conserved in the 
aligned sequences. The highest conservation with respect to 
Pru p 3 is observed in the region comprising the amino acids 
71-80, where only one residue out of ten is substituted in Mor 
n 3, Fra a 3, Vit v 1 and Cor a 8; two residues are substituted 
in Art v 3 and eight residues are substituted in Par j 2. In the 
other two regions, different patterns of substitutions can be 
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observed in each one of the analyzed LTPs. Par j 2 shows the 
highest number of replacements with respect to Pru p 3. The 
three residues R39, T40 and R44, reported to be involved in 
the IgE binding of Pru p 3, are all conserved in Cor a 8. In 
Mor n 3, Fra a 3, Vit v 1 and Art v 3, T40 and R44 are 
conserved, whereas the residue in position 39 is 
conservatively substitued (R39/K39).  
 
1.4. Mor n 3 and Pru p 3 SPT in LTP sensitized subjects  
Twenty-six subjects tested positive to at least one LTP on the 
ISAC system were selected for the analysis by Skin Prick Test 
(SPT). Almost all the selected subjects (96%) were sensitized 
to the peach LTP, Pru p 3. Only one subject IgE negative to 
Pru p 3 was enrolled because of sensitization to the hazelnut 
LTP (Cor a 8). Within this selected group, sensitizations to 
other LTPs were recorded as follows: Art v 3 46%; Cor a 8 
50%; Par j 2 19%. One subject was sensitized to Art v 3 but 
not to Cor a 8, whereas two were sensitized to the hazelnut 
LTP but not to the artemisia LTP. Mor n 3 was positive in SPT 
in 23 out of 26 enrolled subjects (88.46%), exerting reactions 
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comparable to those of Pru p 3. The 25 subjects positive to 
Pru p 3  on the ISAC system, reacted to the Pru p 3 
preparation by SPT.  The subject with a negative ISAC result 
on Pru p 3, was confirmed negative by SPT, but was scored 
positive with the Mor n 3 preparation. In three Pru p 3+ 
subjects, Mor n 3 was recorded negative by SPT. The 
prevalence of Mor n 3+ subjects lacked significant difference 
when compared to Pru p 3+ patients (n=25, 96.15%). 
 
1.5. IgE-binding inhibition by Mor n 3 and Pru p 3 on LTPs 
spotted on the ISAC microarray  
Immunological co-recognition of LTPs was studied by IgE 
inhibition assay, using the high throughput multiplex 
inhibition method SPHIAa assay on the ISAC system.. As 
reported in Figure 10, IgE inhibitions were performed by 
detecting residual IgE binding on LTPs available on the ISAC 
system by incubating single sera with Mor n 3 or Pru p 3. 
Figure 10 shows that all the 12 Pru p 3+ sera were fully  
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Figure 10. IgE cross-reactivity experiments. Single point highest 
inhibition achievable assay (SPHIAa) carried out using Mor n 3 and Pru 
p 3 as inhibitors of IgE binding on Art v 3, Cor a 8, Par j 2 and Pru p 3 
immobilized on the ISAC microarray.  
 
 
inhibited by the homologous natural preparation. Mor n 3 
produced almost the same results on the same allergen with 
inhibition values ranging between 83% and 100%, except for 
one sample where a 62% inhibition value was obtained. Both 
Mor n 3 and Pru p 3 showed an almost full inhibition on all 
Cor a 8+ samples. IgE inhibition on seven Par j 2+ samples 
was negligible when Pru p 3 was used as inhibitor, whereas 6 
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out of 7 sera showed a slight inhibition using Mor n 3 
preparation as inhibitor, with values ranging between 15% 
and 47%. 
1.6. Detection of LTP in kiwifruit pulp and seeds 
Seed and pulp extracts of green and gold kiwifruit were 
prepared as described in the Materials and Methods section, 
fractionated by RP-HPLC (Figure 11-12, panels A-B) and the 
separated protein components were manually collected and 
analyzed by N-terminal amino acid sequencing. The analysis 
of a peak eluted at a retention time very similar to that 
observed for Pru p 3 allowed the identification of LTP, 
namely Act c 10 and Act d 10, in the seed extracts from gold 
and green kiwifruit, respectively (Figure 11). Act c 10 was 
eluted as a single peak, whereas Act d 10 was eluted in three 
overlapping peaks suggesting the presence of some isoforms. 
Direct protein sequencing of the purified protein allowed the 
identification of two different isoforms of Act d 10 (see 
below). Possible additional isoforms were not identified 
probably because of the low yield.  
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Conversely, the LTP peak was absent in the RP-HPLC 
profiles obtained for the pulp extracts of the two kiwifruit  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 11. RP-HPLC profiles of the seed (A) and pulp (B) protein 
extracts of green kiwifruit tissues. The amount of loaded proteins was 
1 mg. The arrow indicates the elution time of Act d 10.  
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Figure 12. RP-HPLC profiles of the pulp (B) and seed (A) protein 
extracts of gold kiwifruit tissues. The amount of loaded proteins was 
0.3 mg. The arrow indicates the elution time of Act c 10.  
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species (Figure 11-12, panels B). Nevertheless, the fractions 
of pulp extracts eluted at the retention time of Act d 10 and 
Act c 10 were collected and analyzed by N-terminal amino 
acid sequencing. The results obtained suggested the absence 
of detectable amounts of Act d 10 and Act c 10 in the pulp 
extracts. 
 
1.7. Act d 10 and Act c 10 purification 
Act c 10 and Act d 10 were purified from the seed extracts 
using the procedure described in the Materials and Methods 
Section for the purification of Mor n 3. The recovery of the 
pure protein was about 0.4 mg per gram of green and gold 
kiwifruit seeds. Protein concentration was estimated on the 
basis of the molar extinction coefficient at 280 nm (3480 M-1 
cm-1). Protein preparation resulted pure upon analysis by 
SDS-PAGE and coomassie staining, RP-HPLC and N-
terminal amino acid sequencing. 
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1.8. Primary structure of Act d 10 
 Direct sequencing of the N-terminal region of native Act d 10 
provided the following sequence: AVSCGQVDTALTPCLTY 
(Figure 13).  
 
 
Figure 13. Amino acid sequence of green kiwifruit LTP, Act d 10. 
Arrows indicate fragments obtained by enzymatic digestion with 
trypsin (T), Asp-N (D) and chymotrypsin (C). The amino acid sequence 
of the N-terminal region obtained by direct sequencing of native Act d 
10 is indicated by N-term. Peptides are numbered according to their 
order in the sequence. 
 
 
 
A small fraction of the molecules contained the amino acid 
threonine (T) rather than alanine (A) as first residue. The N-
terminal sequence of Act c 10 was identical to that of Act d 10 
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(AVSCGQVDTALTPCLTY), and no heterogeneity at first 
position was observed. The complete primary structure of 
Act d 10 was determined by sequencing of peptides obtained 
from the enzymatic digestion of denatureted and alkylated 
protein. Most of the amino acid sequence was obtained by 
aligning the sequence of peptides produced by trypsin and 
Asp-N digestions, whereas the regions corresponding to the 
residues 18-35 and 36-42 were elucidated by sequencing 
fragments from chymotrypsin digestion. Figure 13 shows 
only the peptides necessary to elucidate the complete amino 
acid sequence. Act d 10 comprises 92 residues producing a 
molecular mass of 9,458 Da for the most abundant isoform, 
having the alanine at the N-terminus. The 100% sequence 
identity in the N-terminal region, together with the 
observation that Act d 10 and Act c 10 show the same 
chromatographic behavior and very similar molecular masses 
as estimated by mass spectrometry analyses (see below), 
suggested a very high structural similarity between the two 
proteins. Therefore, only the full Act d 10 primary structure 
was elucidated. The amino acid sequence of the Act d 10 
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isoforms having alanine (A) or threonine (T) as N-terminal 
residue, and the partial N-terminal sequence of Act c 10, were 
registered in the Uniprot knowledgbase with the accession 
numbers P85205, P85206, and P85204, respectively. 
 
1.9. Estimation of the molecular mass of kiwifruit LTPs by mass 
spectrometry 
The analyses by MALDI-TOF mass spectrometry of purified 
Act d 10 provided two values, 9,464 and 9,484 kDa. These 
values are in good agreement with the molecular masses 
deduced from the amino acid sequence of the two isoforms 
having alanine (9,458 kDa) or threonine (9,488 kDa) as N-
terminal residue, respectively. A molecular mass of 9,460 kDa 
was obtained by mass spectrometry for Act c 10. 
 
1.10. Evaluation of the resistance to proteolysis  
The analysis by SDS-PAGE and RP-HPLC of Act c 10 and Act 
d 10 subjected to digestion by SGF or trypsin as described in 
the Materials and Methods section showed that, they both are 
resistant to proteolysis.  
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1.11. Analysis of Act d 10 primary structure  
Homology search in Uniprot protein database carried out 
using BLAST algorithm showed the sequence identity 
between Act d 10 and other already known allergenic LTPs to 
be not very high, ranging from 55% to 35% with Ara h 9 and 
Par j 2, respectively. Identities among the amino acid 
sequence of the six allergenic LTPs under study (Act d 10, 
Ara h 9, Art v 3, Cor a 8, Mor n 3 and Pru p 3) are comprised 
in the range 42-70% (Table 2). The identities between Act d 
10 and other LTPs, such as Api g 2 (celery stalk), Cit s 3  
 
 
Table 2. Amino acid sequence identity (%) among LTPs from different 
sources 
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(orange), Fra a 3 (strawberry), Lac s 1 (lettuce), Len c 3 
(lentil), Lyc e 3 (tomato), Mal d 3 (apple), Ori s 14 (rice), Pla or 
3 (plane tree pollen), Pru du 3 (almond), Pyr c 3 (pear), Sin a 3 
(mustard), Tri a 14 (wheat), Vit v 1 (grape) and Zea m 14 
(maize) are comprised in the narrow range of 40-55% (data 
not shown). The multiple alignment of the amino acid 
sequence of Act d 10 with some other LTPs, namely Ara h 9, 
Art v 3, Cor a 8, Mor n 3 and Pru p 3 (Figure 14) underlines 
that the best conserved region is a stretch of 10 contiguous 
residues (positions 45-54, Act d 10 numbering).  
 
 
Figure 14. Sequence alignments of Act d 10, Ara h 9, Art v 3, Cor a 8, 
Mor n 3 and Pru p 3. Identical amino acid residues are highlighted in 
yellow; in blue are identical amino acids in Act d 10 and Pru p 3 and 
some other LTP sequences; in green are amino acids of Act d 10 
substituted in Pru p 3, but conserved in at least one of the other 
sequences; in red are amino acids of Pru p 3 substituted in Act d 10, but 
conserved in at least one of the other sequences; in brown are identical 
amino acids only in Act d 10 and Pru p 3; in white are residues of Act d 
10 not conserved in any other sequence. 
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Twenty-four amino acid (26%) (yellow background) are 
conserved in all the six aligned sequences, including the eight 
cysteine residues. Act d 10 shares 18 additional residues with 
Pru p 3: two of them (brown background) are only conserved 
in Act d 10 and Pru p 3, whereas the remaining 16 shared 
residues (blue background) can be found also in other 
aligned sequences but not all of them. Twenty-one residues 
(23%) of Act d 10 are substituted in Pru p 3, whereas they are 
conserved in at least one of the aligned sequences (green 
background). A higher number of residues, that is 35 amino 
acids of Pru p 3 (38%), are substituted in Act d 10, but they 
are conserved in at least 1 of the other sequences (red 
background). Act d 10 and Pru p 3 do not share identical 
residues with any of the other aligned sequences in 27 and 14 
sequence positions, respectively (white background). 
 
68 
 
1.12. Analysis of a group of kiwifruit allergic patients sensitized to 
LTPs 
Patients selected for this investigation reported a reliable 
clinical history of reactions when eating kiwifruit. Their 
diagnostic profile is reported in Table 3. The IgE screening 
performed using the ISAC system showed that six out of 
seven subjects were not sensitized to other kiwifruit 
allergens, and only one subject was recorded positive to the 
kiwifruit allergen Act d 1, but all were positive to Pru p 3, the 
homologous peach LTP. 
 Results obtained by testing the patients with a commercial 
kiwifruit extract both by SPT and CAP were sometime 
negative (Table 3). All patients underwent DBPCFC and 
showed symptoms following the ingestion of kiwifruit. They 
also showed a positive reaction following in vivo testing by 
SPT. Detection of IgE in the sera of the selected subjects was 
carried out using the biotinylated kiwifruit LTPs coupled 
with streptavidin-CAP. Results obtained showed that all the 
subjects had IgE specific for Act d 10 and Act c 10, whereas 
they were negative in 10 allergic subjects used as controls. 
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Table 3. Diagnostic profiles of seven selected kiwifruit allergic patients 
enrolled for the initial characterization of kiwifruit LTPs 
 
 
 
 
 
1.13. Comparative analysis of reactivity towards different LTPs 
A large population was analyzed using the routine testing 
approach by the ISAC microarray, in order to define any 
possible subsets related to different LTP IgE recognition. A 
comparative evaluation of seven LTPs was undertaken using 
the ISAC 103 and ISAC Exp96 microarrays in parallel. A 
population of 431 subjects positive to at least one LTP was 
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selected and analyzed. Act c 10, Act d 10, Ara h 9, Art v 3, 
Cor a 8, and Mor n 3 were positive when Pru p 3 was 
negative in 48, 41, 17, 56, 43, and 17 cases, respectively. The 
number of subjects positive to one LTP as listed above and 
negative to all others was relatively low, being 5, 0, 9, 25, 10, 
9, 17. These prevalence were statistically different only when 
considering Art v 3 values versus kiwifruit LTPs, peanut and 
mulberry ones. Raw prevalence are reported in Figure 15, 
calculated on the sub-population of 431 patients tested 
positive to at least one of the seven LTPs.  
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Figure 15. IgE prevalence for Act c 10, Act d 10, Ara h 9, Art v 3, Cor a 
8, Mor n 3, Pru p 3 obtained by testing 431 sera from subjects positive to 
at least one LTP under study. 
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Pru p 3 was anyway the most prevalent sensitization with no 
difference only when compared to Mor n 3. IgE sensitization 
to Act c 10 and Act d 10 had significant higher prevalence 
than the mugwort and the hazelnut LTPs, but lower 
prevalence than Mor n 3 and Pru p 3. The less prevalent IgE 
reactivity have been recorded for the mugwort and the 
hazelnut LTPs being different from all other LTPs.  
To visualize exclusive sensitization to one LTP compared to 
others, a series of Venn diagrams using IgE values obtained 
by microarray testing have been generated and reported in 
Figure 16. The first Venn diagram (Figure 16, panel A) shows 
almost overlapping results between the two kiwifruit LTPs, 
and non-overlapping results considering Act c 10 and Act d 
10 opposed to Pru p 3. Due to the highly similar behavior of 
the two kiwifruit LTPs, Figure 16 shows how each of the 
other four LTPs under study behaves compared to Act d 10 
and Pru p 3.  
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Figure 16. Venn diagrams obtained using specific IgE values for 
different LTPs. Specific IgE for Act d 10, Act c 10, Pru p 3, Mor n 3, Art 
v 3, Cor a 8, determined by the ISAC system, were used. Due to the 
highly similar behavior of the two kiwifruit LTPs, panel from B to E 
show how the other four LTPs behave compared to Act d 10 and Pru p 
3. Absolute and relative IgE prevalence are given for each combination 
on graphs as follows: Panel A: Act c 10, Act d 10, and Pru p 3; Panel B: 
Act d 10, Pru p 3, Ara h 9; Panel C: Act d 10, Pru p 3, Art v 3; Panel D: 
Act d 10, Pru p 3, Cor a 8; Panel E: Act d 10, Pru p 3, Mor n 3.  
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Venn diagrams change depending on individual LTP, further 
showing heterogeneity of the members of this group of 
molecules. An index of the different reciprocal behavior of 
the LTPs is the changing number of isolated positivity to the 
three LTPs used in each graph depending on the third LTP 
used. 
A cluster analysis performed using all the 431 subjects having 
IgE positive results to at least one of the seven LTPs 
produced the heat map shown in Figure 17.  
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Fig 17. Clustering analysis of 431 subjects tested for IgE on seven 
LTPs. Logarithmic IgE value distribution has been used to generate the 
heat map. Subjects had at least one IgE-positive result to one LTP under 
study. LTPs and subjects are reported on the y-axis and x-axis, 
respectively. Black to dark red scale corresponds to IgE values from 
negative to strongly positive. 
75 
 
The picture shows the clustering heterogeneity of both 
allergens and patients. LTP IgE recognition by the sensitized 
subjects is well represented by the presence of the first two 
clusters segregating Art v 3 and Cor a 8 reactivity apart from 
the other LTPs. A second dichotomy is observed, separating 
the two kiwifruit LTPs from the others and showing, as 
expected, the two kiwifruit molecules to be the closest ones. 
The remaining three LTPs form an additional cluster further 
divided in two. In addition, subject clustering is dispersed in 
a great number of clusters, reflecting the individual 
heterogeneity of LTP IgE recognition. 
 
1.14. Experiments of immunological co-recognition among different 
LTPs 
To investigate immunological co-recognition among LTPs, 
the SPHIAa assay was chosen using Act c 10, Act d 10, and 
Pru p 3 as inhibitors of IgE binding on the seven LTPs. The 
assay was carried out using ten individual sera selected for 
being IgE positive to the three inhibitors as shown in Figure 
18, where IgE values for any given inhibited LTP are given  
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Fig 18. Single Point Highest Inhibition Achievable assay (SPHIAa) 
for LTP IgE inhibition (reported as percent inhibition). Inhibitors are 
on the X-axis. LTP immobilized on the microarray whose IgE binding 
was inhibited is on the top of graphs. 
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for each of the ten sera. Full autologous IgE inhibitions on the 
two kiwifruit LTPs were observed, as well as with the 
homologous Pru p 3 preparation (Figure 18, panel A and B). 
Pru p 3 fully inhibited all the other LTPs (panel C to F). The 
two kiwifruit LTPs showed IgE inhibition on the other LTPs 
as follows: greater than 50% on Ara h 9 for all samples; 
spread between 0 and 100% on Art v 3; separated in two 
subgroups, one achieving 100% the other staying below 70% 
on Cor a 8; hardly reaching 100%, and spread in a wide 
range, with the lowest value at 29% on Mor n 3; not reaching 
100%, spread in a wider range, with the lowest value at 19% 
on Pru p 3. Therefore, the inhibition test shows minor 
differences between the two kiwifruit LTPs. Overall, also IgE 
inhibition experiments confirmed the immunochemical 
differences between the two kiwifruit LTPs and the peach 
homolog and a different behavior in terms of epitope 
distribution, recognition and inhibition by the three 
inhibitors. 
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1.15. Analysis of the LTP distribution within the kiwifruit tissues 
by immunological and clinical methods 
A series of experiments were performed to define the LTP 
distribution within the kiwifruit tissues, namely the pulp and 
the seeds, based on immunochemical and clinical methods. 
As the biochemical findings reported above suggested the 
presence of LTP in kiwifruit seeds and its absence in the 
pulp, to increase the confidence with the negative data we 
approached the issue of LTP distribution in kiwifruit tissues 
using the SPHIAa as well. The inhibition was performed 
using the same pulp and seed preparations from the green 
and gold kiwifruits, along with whole kiwifruit extracts. A 
pool of sera having IgE for both the two kiwifruit LTPs was 
used as probe. As shown in Figure 19, full or almost full IgE 
inhibition results were obtained with the whole kiwifruit 
extracts and the seed ones, whereas the pulp gave either no 
inhibition (green kiwifruit pulp on Act c 10, Figure 19, lower 
panel) or inhibition values ranging between 18% and 28% (all 
other pulp/allergen combinations in Figure 19, upper panel). 
These slightly positive results were replicated and could  
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Figure 19. Immunochemical evaluation of LTP distribution in 
kiwifruit tissues. Single Point Highest Inhibition Achievable assay 
(SPHIAa) using pulp and seed extracts from green and gold kiwifruit. 
Green, violet and yellow bars show total kiwifruit, pulp and seeds 
extracts, respectively from green and gold kiwifruit, used as inhibitors 
on Act d 10 (upper panel) and Act c 10 (lower panel) immobylized on 
the ISAC microarray. 
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suggest the presence of very low amounts of LTP in the 
kiwifruit pulp not detected by the biochemical methods. The 
very low inhibition values were anyhow not considered 
conclusive, and needing a third discriminating proof. 
Therefore, in vivo SPT with green kiwifruit seed and pulp 
preparations in 21 selected subjects were performed. Table 4 
shows that some of the patients did react to the pulp. 
 
Table 4. Diagnostic and clinical profiles of patients enrolled because of 
clinical allergy to peach and positive or negative kiwifruit LTP test 
results.  
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As the key values were those obtained on patients having 
severe clinical reactions following kiwifruit ingestion, and 
high or very high SPT and IgE scores when tested with Act c 
10 and Act d 10 (Table 4, lines 15-21), we concluded that tiny 
amounts of LTP are contained in kiwifruit pulp. Therefore, 
clinically allergic patients were not challanged with the 
kiwifruit pulp.  
  
1.16. Analysis of the tolerability of the green kiwifruit by Pru p 3 
positive, Act c 10/Act d 10 negative subjects 
For initial experiments used to identify the new kiwifruit 
LTPs, patients with combined clinical and IgE reactivity to 
kiwifruit and peach had been enrolled.  Then, experiments to 
define the in vivo clinical reactivity to green kiwifruit in well 
characterized peach allergic patients were planned. We thus 
recruited patients having different diagnostic profiles. All 
enrolled subjects were Pru p 3 positive with either a positive 
DBPCFC to peach or a recent severe generalized reaction 
following peach ingestion. All underwent the tests as 
reported in Table 4. Fifteen of them passed the DBPCFC 
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eating a full kiwifruit at the end, and six clearly showed 
symptoms after the challenge. The latter were all tested 
positive for almost all preparations either by in vivo or in vitro 
tests, whereas among the kiwifruit tolerant subjects in the 
majority of the cases the kiwifruit LTP were tested with 
negative results, but with exceptions, unless positive values 
were in the lowest range for both ISAC and SPT tests (Table 
4). In the attempt to explain why the Act c 10 or Act d 10 
positive results were sometimes not associated to clinical 
reactivity, we simulated physiological digestion of the two 
kiwifruit LTPs as reported above, and, using the SPHIAa, 
evaluated the retained capability to induce IgE inhibition. Pru 
p 3 was comparatively evaluated, as it is known to be 
resistant to digestion. The results showed that Act c 10 and 
Act d 10 subjected to digestion with SGF and tryspsin are still 
active in the IgE inhibition assay. 
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 1.17. Identification, purification and biochemical and 
immunological characterization of Lyc e 7kDa from tomato  
 
1.18. Detection and purification of Lyc e 7kDa  
A protein extract from tomato (Solanum lycopersicum) seeds 
was prepared as described in the Materials and Methods 
Section, fractionated by RP-HPLC (Figure 20) and the 
separated protein components were manually collected and 
analyzed by amino acid sequencing. The analysis by N-
terminal amino acid sequencing (see below) of a peak eluted 
at a retention time close to that observed for other LTPs, such 
as Act d 10 (see above), allowed the identification of a 7-kDa 
LTP (Lyc e 7kDa).  
Lyc e 7kDa was purified from tomato seeds extract 
following the procedure used to purify Mor n 3 (see Materials 
and Methods Section). The recovery of the pure protein was 
0.07 ·mg/1 gram of seeds. Protein concentration was 
estimated on the basis of the molar extinction coefficient at 
280 nm (1490 M-1 cm-1). The purity of the protein preparation 
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was checked by SDS-PAGE and Coomassie staining, RP-
HPLC and N-terminal amino acid sequencing. 
 
 
 
 
 
 
 
 
 
Figure 20. RP-HPLC profile of the protein extract of tomato seeds. The 
amount of loaded proteins was 1 mg. The arrow indicates the peak of 
Lyc e 7 kDa LTP. 
 
 
 
1.19. Primary Structure of Lyc e 7kDa and homology search 
The first 15 residues (ATCSASQLSPCLGAI) of the N-
terminal region of Lyc e 7kDa were identified by direct 
sequencing of the native protein. The homology search in 
Uniprot Database revealed the absence of tomato LTP having 
the same N-terminus. Conversely, the homology search in the 
EST database using tblastn (www.expasy.org), at NCBI, 
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allowed the identification of a clone (BW690549) coding for 
the tomato 7-kDa LTP (Figure 21). This protein comprises 68 
amino acids producing a molecular mass of 7045 Da. This 
value is in good agreement with the experimental value 
obtained by MALDI-TOF mass spectrometry (7026 ± 20 Da) 
measurement carried out on the purified Lyc e 7kDa. 
 
 
Figure 21. Primary structure of Lyc e 7kDa. The eight cysteine residues 
conserved in the homologous proteins are highlighted in yellow. 
 
 
Homology search in Uniprot database carried out using 
BLAST (www.expasy.org) has shown that the amino acid 
sequence of Lyc e 7 kDa displays high sequence identity with 
several already known 7 kDa LTPs (LTP2). The values of 
sequence identity between some representative components 
of the family of 7-kDa LTPs, ranging from 43 to 82%, is 
shown in Table 5. For comparative purposes, the identity 
values between some LTP1 have also been reported  
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Table 5. Amino acid sequence identity (%) between LTPs from different 
sources. Sequence identities between LTP belonging to the LTP1 or LTP2 
protein families are highlighted in orange and heavenly, respectively. White 
background has been used to highlight sequence identities between LTP1 and 
LTP2 proteins. 
 
 
 
in the Table. They fall in the range  43-82%. Conversely, low 
sequence identities were obtained when components of the 
family of LTP2 were compared to those of LTP1. The highest 
value (35%) was recorded by comparing the tomato 7-kDa 
sequence (Lyc e 7 kDa) and the peach LTP1 (Pru p 3). 
Figure 22 shows the alignment of the amino acid sequence of 
Lyc e 7 kDa with that of homologs belonging to the LTP2 
family and some components of the LTP1 family.  
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Figure 22. Multiple sequence alignment of LTPs from different 
sources. In blue are the residues conserved in all sequences, in green 
the residues conserved in the group of LTP2 and in pink the residues 
conserved in the group of LTP1. 
 
 
In particular, the sequences of LTP2 from barley (Horvu), 
potato (Soltu), soy (Soybn), rice (Orysj), maize and wheat and 
allergenic LTP1 from kiwifruit (Act d 10), peanut (Ara h 9), 
artemisia (Art v 3), hazelnut (Cor a 8), mulberry (Mor n 3), 
peach (Pru p 3) and tomato (Lyc e 3) were aligned using the 
CLUSTAW algorithm (www.expasy.org). The multiple 
alignment (Figure 22) shows that to align LTP1 and LTP2 
sequences, displaying  significant differences at the primary 
structure level, it was necessary to insert two gaps in the 
LTP2 sequences. In addition to the eight cysteine, only Q31 is 
conserved in all the aligned sequences.  
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1.20. Immunological and clinical characterization of Lyc e 7kDa 
Purified Lyc e 7kDa was immobylized on a customized ISAC 
microarray, where other allergens, including other allergenic 
LTP, were spotted. A population of 18 subjects allergic to 
tomato were selected and analyzed by the ISAC system. 
Symptoms reported following tomato ingestion were: OAS (9 
subjects), dyspnea (4 subjects), gastritis (3 subjects), enteritis 
(1 subject), food-dependent exercise-induced anaphilaxis 
(FIDEIA, 1 subject). The analysis of these subjects revealed 
that 15 patients (83%) had IgE specific for Lyc e 7kDa. 
Positive results were also recorded for other spotted LTP. 
Figure 23 shows the prevalence of subjects positive to Lyc e 
7kDa compared to those recorded for other allergenic LTPs, 
such as Pru p 3, Mor n 3, Art v 3, Ara h 9, Act d 10 and Act c 
10. 
The analysis of a larger population (89 subjects), IgE positive 
to at least one LTP, showed that 45 subjects (50%) had IgE 
recognizing Lyc e 7kDa.  
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Figure 23. Prevalence of IgE specific for Lyc e 7kDa compared to those 
found for other allergenic LTPs belonging to the LTP1 family. 
 
Thirty-four allergic subjects underwent in vivo testing by SPT. 
Eight of them (23%) gave a positive reaction to the purified 
protein.  
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2. Influence of chemico-physical features of the 
environment on the protein conformation and the IgE 
reactivity: kiwellin (Act d 5) as a model (36) 
 
2.1. Skin Prick Test with kiwifruit extracts and purified  Act d 5  
Protein extracts from green kiwifruit and purified kiwellin 
(Act d 5) were prepared as described in Materials and 
Methods Section. Twenty-nine subjects were selected on the 
basis of a reliable history of allergic reactions to kiwifruit. 
Patients were tested with both commercial and in-house 
prepared green kiwifruit extract, and with Act d 5 in a 
neutral solution (pH 7.4), and in acidic water solution (pH 
4.5). 
Eleven subjects out of 29 (38%) reacted to the purified 
Act d 5  by SPT. Among them, 3 patients (10%) showed a 
reaction only to Act d 5 at pH 4.5, three (10%) showed a 
reaction only to the allergen in neutral environment and five 
(17%) showed a reaction to Act d 5 solubilized in both the 
environments. Some features of the eleven subjects reacting 
to the SPT, in at least one condition, are listed in Table 6. 
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Table 6. Clinical data of the population under study showing  
positive SPT to Act d 5 
 
 
 
 
 
 
 
 
 
 
 
 
This population includes 7 female and 4 male. Six patients 
reported oral symptoms (O), one patient edema and oral 
symptoms (E, O), one patient vomiting (V). Three patients 
had asthma (A): one togheter with atopic dermatitis (D), one 
with urticaria (U) and another with skin itching (P). 
All the 11 subjects with a positive SPT to purified Act d 5, 
were tested with both commercial and in-house kiwi extract 
by SPT. Two of them (7%) had no reaction to the commercial 
extract, whereas all patients reacted to the in-house prepared 
kiwifruit extract. 
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2.2. IgE binding experiments 
Eleven subjects with positive SPT were also tested on Act d 5 
immobilized on the ISAC system. As shown in Table 6, no 
one of the tested sera recognized the immobilized Act d 5. 
Ten patients out of 11 were tested for specific IgE to green 
kiwi extract using the CAP system, and seven of them 
showed high IgE levels. (Table 6). 
Sera of 9 subjects among those showing a positive SPT were 
used to test Act d 5 by IgE immunoblotting experiments 
(Figure 24). Eight out of nine sera contained specific IgE 
recognizing Act d 5 from both reducing and non-reducing 
conditions. Nevertheless, a variation of the signal intensities 
was observed, and generally the signals shown by the non-
reduced Act d 5 were weaker than those observed for the 
reduced allergen. 
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Figure 24. IgE immunoblotting of Act d 5. The allergen was probed 
with nine individual sera (lanes 1–9, Table 5) and with buffer as a 
negative control for the anti-human IgE antibody (lane C). 
 
 
2.3. Circular dichroism studies 
A study of the structural properties of Act d 5 has been 
performed by circular dichroism (CD) in different 
experimental conditions, to evaluate the effect of different 
environments on the protein conformation. Spectra have been 
acquired at pH 7.5, close to the human physiological value, 
and at pH 4.5, close to the acidic value of the kiwi fruit. 
Furthermore, the influence of lower polarity media has been 
investigated, trying to reproduce the chemico-physical 
features of membrane-like environments, where the 
interaction between Act d 5 and its target cell takes place. 
Water/fluorinated alcohol mixtures represent a handily 
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medium to simulate biological environments of low and 
medium polarity (37), and have successfully been used to 
characterize the conformation of several bioactive peptides in 
membrane-like environments (38-40). Figure 25 shows the 
CD spectra obtained at pH 7.5 (upper panel) and pH 4.5 
(lower panel) in the different experimental conditions 
explored. The analysis of the CD curves shows that all of 
them display the typical shape of a mainly helical structure, 
characterized by two minima around 222 and 206 nm, 
although the not-fully canonical shape indicates the 
contribution of other secondary structures, namely alfa-
structures and/or random-coils. In addition, the comparison 
among the two panels reveals that the curves obtained at 
lower pH (lower panel) are in general more intense than the 
curves obtained around a neutral pH (upper panel), 
suggesting a higher degree of structure at acidic pH. 
Furthermore, at pH 4.5, the differences among the curves are 
well evident, and indicate that in the presence of both 
fluorinated alcohols the fraction of folded molecules 
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Figure 25. Structural characterisation. Circular dichroism spectra of Act 
d 5 at pH 7.5 and 4.5 and in mixtures of  trifluoroethanol (TFE) and 
hexafluoroisopropanol (HFIP).  
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increases. Conversely, at pH 7.5 all the curves are more or 
less superimposed.  
Figure 26 underlines the effect of the experimental 
conditions on Act d 5 structure. It reportes the molar 
ellipticity at 206 nm, which represents one of the hallmarks of 
helical structures, in the different experimental conditions 
analyzed. In this representation it is well evident that in fully 
 
 
Figure 26. Helical content in Act d 5 under different experimental 
conditions.  
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polar media (represented by bulk water) the protein is less 
structured and there is no pH effect. This behavior is not 
affected by the addition of a low amount of TFE (20 % by 
volume), but becomes more pronounced as far as the 
medium polarity decreases, i.e. in 80 % TFE and in the 
presence of HFIP, both at 20 and 80% by volume. Overall, the 
data reported here indicate that the conformation of Act d 5 is 
strongly affected by the chemico-physical features of the 
experimental conditions, first of all by the solvent polarity. In 
general, Act d 5 appears more structured in low polarity 
media and at low pH. 
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3. Sensitivity to the gastrointestinal digestion and effect on 
human intestinal tissue of the kiwifruit peptide kissper 
 
3.1. Kissper purification from green kiwifruit 
Several ripe kiwifruit batches were analyzed in order to 
assess the concentration of the peptide kissper in the protein 
extracts. The analysis of the kissper content in the kiwifruit 
protein extracts was performed by RP-HPLC 
chromatographic separation. The fruits containing high 
amounts of peptide were selected and used as starting 
material for kissper purification, following the procedure 
described in the Materials and Methods Section. The purity of 
the preparation was checked by RP-HPLC analysis and N-
terminal amino acid sequencing.   
 
3.2. Treatment of the peptide kissper with gastrointestinal proteases 
Treatment  of the peptide kissper with SGF and SIF was 
performed as described in the Materials and Methods 
Section. The analysis by RP-HPLC of all the aliquots taken at 
0 and 120 min of incubation showed a single peak eluted at 
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the retention time of the native peptide, thus indicating that 
kissper was resistant to the treatment with pepsin, trypsin 
and chymotrypsin. The absence of proteolytic cleavages was 
also confirmed by N-terminal amino acid sequencing analysis 
of the aliquots taken at 120 min of incubation, where, in fact, 
only the N-terminal sequence of the native peptide was 
obtained. 
 
3.3. Influence of the peptide kissper on human colonic mucosal 
inflammation  
To investigate a possible influence of the peptide kissper on 
the human colonic mocosa, biopsy specimens from subjects 
suffering from Crohn’s desease (CrD) were analyzed by 
detection of the expression of some pro-inflammatory 
cytokines. In particular, the release of TNF-alfa, COX-2 and 
ICAM-1 after stimulatation by Escherichia coli 
lipopolysaccharide LPS (EC-LPS) was recorded. The 
immunohystochemical analysis of the tissue shows that the 
treatment with  EC-LPS toxin induced a strong increase of the  
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Figure 27. Effect of kissper on the expression of COX-2, ICAM-1 and 
TNF-alfa after incubation with EC-LPS for 4 h in intestinal biopsies 
from patients suffering from Chron disease. 
(A) increased expression of COX-2 and ICAM-1 after challenge with 
EC-LPS. Pretreatment with kissper reduced their expression at the level 
observed in the tissue incubated with medium only.  
(B) Pretreatment with kissper reduced the release of TNF-alfa by  EC-
LPS treatment. 
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cytokines expression. However, pre-treatment with the 
peptide kissper efficiently counteracted this effect by 
controlling the level of released COX-2 and ICAM-1, that was 
mantained as low as the control (Figure 27A). Figure 27B 
shows that the pre-treatment with kissper nullifies the effect 
of EC-LPS on the cellular TNF-alfa concentration. In fact, the 
increased concentration induced by EC-LPS was not 
observed in the presence of kissper.  
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DISCUSSION 
The knowledge of molecules contained in foods and their 
properties allows the development of the best and safest diet 
for each subject. This is especially important for allergic 
subjects, that needs to avoid allergy sources. In addition, it is 
also very helpful for people suffering from dysfunctions or 
diseases that, in some cases, can find a significant 
improvement of their health by the consumption of specific 
functional foods or the use of nutraceuticals (18-20). In this 
framework, the study described in this thesis provides new 
information in the field of allergology and nutraceutical 
molecules. In fact, results obtained include the identification 
and characterization of new allergens from plant foods and at 
least a partial characterization of a bioactive kiwifruit peptide 
as an anti-inflammatory molecule. 
Kiwifruit has been chosen as a model of food endowed with 
beneficial effects on human health and also an important 
source of food allergy. In fact, both the properties have been 
widely described in literature (21-23) (12, 26). However, the 
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molecules responsible of beneficial effects and the molecular 
mechanisms involved in their biological activity are still 
unknown, as well as not all the allergenic kiwifruit molecules 
have been described. 
Lipid transfer protein (LTP) is an ubiquitous plant protein. It 
is also a very important allergen (8, 41). For instance, LTP 
from peach fruit is well known as a molecule that can cause 
severe allergic reactions, such  as the anaphylactic shock (35). 
In kiwifruit, LTP had never been reported before. Here we 
describe for the first time the identification of LTP in 
kiwifruit and the characterization of its immunological 
properties. It has been identified both in green and gold 
kiwifruit and on the basis of immunological and clinical 
properties it has been included in the official list of allergens 
of the World Health Organization/International Union of 
Immunological Societies (WHO/IUIS) with the allergen  
names Act d 10 and Act c 10. Kiwifruit LTP was found in 
high amounts in the seeds, whereas the pulp seems to contain 
a very low amount of this allergen. This result suggests that, 
at least subjects reacting with mild symptoms to kiwifruit 
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LTP ingestion, can eat this fruit if they care to remove the 
seeds. Moreover, the absence of good quantity of the LTP in 
the pulp raises doubts about the usefulness of the prick-prick 
test technique as reported negative in some subjects in the 
present study (34). 
 
LTP are small proteins divided in two sub-families on the 
basis of the molecular weight: the group of  LTP1 (9-kDa) and 
the group of LTP2 (7-kDa) (3). The kiwifruit LTP described in 
this thesis belongs to the sub-family of LTP1. Anyhow, all the 
allergenic LTP described so far belong to the LTP1 sub-
family. Some allergenic homologs of kiwifruit LTP, that is 
included in the group of LTP1, have been selected and used 
for comparative studies. In addition, the study of an LTP 
belonging to the sub-family 2, isolated for tomato, has been 
undertaken. 
A new allergenic LTP1, used for comparative analysis, has 
been identified in black mulberry (33). Allergy to this fruit 
had already been reported in literature, but the responsible 
molecule(s) had not yet been described. We identified the 
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LTP1 in the fruit of mulberry. After immunological and 
clinical characterization it was included in the WHO/IUIS list 
of allergens with the name of Mor n 3 and it represents the 
first allergenic molecule reported for black mulberry. The 
analysis of the structural features of Mor n 3 reveals that it 
has a very high similarity with the well known allergenic 
peach LTP, Pru p 3. In fact, the sequence identity between 
Mor n 3 and Pru p 3 is high (70%). In line with the structural 
evidence, the immunological and clinical behavior is very 
similar. Conversely, the structural features of kiwifruit LTP, 
Act d 10, indicate that this LTP is not closely related to 
anyone of the already known allergenic LTPs, including Mor 
n 3 and Pru p 3. In fact, the sequence identities between Act d 
10 and Mor n 3 and Pru p 3 are 48% and 46%, respectively.  
The alignment of Act d 10 sequence with the five LTPs 
included in this study (Ara h 9, Art v 3, Cor a 8, Mor n 3, Pru 
p 3) shows that depending on the compared sequences pair, 
unique combinations of conserved residues occurr. The 
absence of sequence regions conserved in all the LTP1 
suggests that the existence of even one identical epitope, 
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shared by all the allergenic LTP1, is unlikely. It is coincevable 
that a complete or partial epitope sharing can be found only 
when closely related LTPs are compared. The observed 
sequence micro-heterogeneity, mainly found in distantly 
related LTPs, could be thus the main cause of heterogeneous 
epitope patterns producing inhomogeneous LTP IgE 
recognition as shown by the results obtained following 
inhibition tests using the ISAC microarray technology (16, 42, 
43). In fact some subjects were IgE positive to some LTPs and 
negative to some others. To the heterogeneous epitope 
pattern present in the different LTPs could also be ascribed 
the results obtained by in vivo tests on allergic subjects. In 
fact, in addition to subjects showing positive reaction to both 
peach and kiwifruit LTP, few subjects reacted only to LTP 
from one fruit and did not react to the other. The observation 
that some subjects have isolated IgE positivity to single LTP 
provides useful information on what to exclude but, most 
importantly, on what to leave in patient’s diet. In addition, 
these results underline that the concept “one allergen fits all 
the homologs”, that is sometimes applied (44-46), may 
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produce some erroneous diagnosis. For instance, there is the 
trend to use the peach LTP, Pru p 3, to assess the allergy to all 
the plant LTP. In line with data recently reported for a 
kiwifruit Bet v 1-like allergen (32), the results here reported 
clearly indicate that the biochemical grouping of allergens 
can be misleading in the allergy diagnosis and that an 
improved allergy diagnosis can be obtained by testing every 
single patient with the most comprehensive panel of 
available LTPs/allergens . 
During the last decade, several efforts have been done 
to improve allergy diagnosis by integrating the traditional 
methods, based on protein extracts from natural raw 
materials, with components based on purified natural or 
recombinant allergens (47-50). 
Purified natural kiwellin (Act d 5) was used to perform 
different in vitro and in vivo tests. By testing a population of 
subjects allergic to kiwifruit using a standard protocol for 
SPT, 8 out of 29 (28%) had a positive reaction. However, the 
number of positive reactions to SPT increased when an 
additional modified protocol was used. In fact, 3 additional 
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positive reactions (10%) to SPT were observed using Act d 5 
in acidic solution, that is an environment more similar to that 
of the natural source. The observation that some subjects had 
a positive reaction either at neutral or acidic pH values 
suggest that this allergen, depending on the environmental 
conditions, may expose different epitopes. Nevertheless, 
some subjects may have IgE antibodies recognising epitopes 
exposed in each of the two examined environmental 
conditions. The conformational analysis by CD 
measurements in different experimental conditions indicate 
that Act d 5 3D structure is modulated by the solvent pH and 
polarity (36). In fact, the protein, having a mainly helical 
conformation, is more structured in low polarity media and 
at acidic pH value, rather than in neutral and fully polar 
media. Therefore, Act d 5 displays pH-driven conformational 
changes but this effect is more evident in a low-dielectric 
costant medium, that is representative of several cellular 
environments (37), like for instance the interior of biological 
membranes. During the transit in the gastrointestinal system, 
Act d 5 can encounter environments characterized by 
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different pH values, ranging from the very acidic one of the 
stomach to values close to neutrality, and can meet 
hydrophobic environments, for instance when approaching 
cell membranes. Therefore, it may be hypothesized that, 
depending on the environments encountered, this allergen 
may undergo in vivo conformational changes and expose 
different epitopes, inducing the synthesis/interaction of 
different specific IgEs. 
IgE-immunoblotting experiments indicate that most of the 
subjects displaying reactivity to Act d 5 by SPT also recognize 
sequence epitopes. In fact, eight out of nine subjects analysed 
by immunoblotting show IgEs reacting with denatured Act d 
5. One subject did not recognize sequence epitopes and 
reacted to SPT only with Act d 5 at acidic pH, and not with 
Act d 5 in neutral condition. Therefore, this subject could 
have IgE antibodies recognizing only the conformational 
epitopes exposed in acidic conditions. These epitopes cannot 
be revealed by test systems using neutral pH conditions, such 
as those using the classical PBS buffer, and cannot be 
revealed by IgE immunoblotting. Probably, the only way to 
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detect the reactivity to Act d 5 of this subject is the prick by 
prick test, performed with the fresh kiwi fruit having its 
naturally acidic pH value. Otherwise, the SPT performed 
with the purified molecule in acidic conditions may represent 
a useful alternative. 
On the basis of the results obtained by the characterization of 
Act d 5 it may be suggested that the environmental condition, 
such as the pH value of the allergen source, could be an 
additional factor affecting the sensitivity of allergy test 
performances. In fact, the structural features and, therefore, 
the ability of some allergens to interact with specific 
antibodies could be different in environments similar to those 
of the natural sources respect to other experimental 
conditions. This is an aspect to which usually very low or 
even no attention is paid. Similar to Act d 5, it can be 
imagined that, depending on the environmental conditions, 
other allergens may undergo conformational changes 
associated with the exposition of different combinations of 
epitopes recognized by the IgE antibodies of allergic subjects. 
This behavior may affect in a very significant way the results 
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of allergy testing, both in vitro and in vivo. Therefore, this is 
an additional factor to be considered in the evaluation of 
allergy test system reliability.  
Therefore, this study on kiwellin, Act d 5, indicates that the 
3D structure of this allergen is sensitive to the physico-
chemical characteristics of the environment. The protein may 
undergo pH- and polarity-driven conformational changes 
that may affect the pattern of exposed antigenic epitopes. 
This behaviour may have an influence on the sensitivity of 
diagnostic tests, such as SPT. Therefore, a deep knowledge of 
the physico-chemical properties of allergenic proteins would 
be desirable and potentially useful for the improvement of 
diagnostic test systems. 
The functional characterization of kissper (28, 29) has 
shown that this food peptide can have beneficial effects on 
human health. A previous study had shown that kissper is 
able to form ion channels and transport ions, preferentially 
anions, in synthetic plasmatic membranes. This property has 
suggested a potential farmaceutical use of this molecule in 
the treatment of pathologies involving an insufficient anion 
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transport, such as cystic fibrosis, constipation, etc. The 
exploitation of a molecule as a nutraceutical includes the 
analysis of several aspects. The study described in this thesis 
had the aim to investigate the influence of kissper on the 
intestinal tract in order to exclude possible negative effects. 
The results obtained on human colonic mucosa deriving from 
biopsy performed on subjects suffering from Crohn’s desease 
clearly exclude an harmful effect of kissper on this tissue. 
Even better, immunohystochemical and ELISA experiments 
have shown the capacity of kissper to suppress the release of 
inflammatory cytokines, such as COX-2, ICAM-1 and TNF-
alfa, after the induction of inflammation by the E.coli toxin 
EC-LPS. This result suggests a possible use of kissper as a 
nutraceutical molecule in the treatment of inflammation and 
prompts further studies in order to verify this potentiality 
and to investigate the mechanism by which the biological 
activity is reached. 
In conclusion, the research work here described has led 
to the identification of four new allergens that have been 
characterized at the biochemical and immunological level. 
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The identification of these new allergens can be helpful to the 
allergologists in the formulation of a safe diet for individual 
allergic subjects. In addition, this information could 
contribute to the improvement of allergy diagnosis following 
the inclusion of these new allergens in the available 
diagnostic systems. The study performed on kiwellin has 
demonstrated that the physico-chemical features of the 
environment can affect the conformation and the IgE 
reactivity of Act d 5. Therefore, this result shows that the 
experimental conditions could affect the response of allergy 
diagnostic systems by modulating the pattern of exposed 
antigenic epitopes. The functional characterization of kissper, 
the peptide naturally occurring in green kiwifruit, indicates 
that the health-promoting effects reported for this fruit 
probably cannot be ascribed only to the usually mentioned 
vitamins and fibers content. Kissper seems to be a 
nutraceutical molecule the potential pharmaceutical use of 
which is worthy of being considered. 
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